Main description:

This book examines the application of stem cell surgery for diabetes and heart failure.

Organized into two sections, the first identifies and summarizes the current worldwide stem cell trials for heart failure. Subsequent chapters in part two analyze the current worldwide stem cell trials in patients with Diabetes Mellitus. Both sections utilize studies that include non-expanded stem cells; each study is grouped by stem cell type and geographic location.

Stem Cell Surgery Trials in Diabetes and Heart Failure is a comprehensive, convenient reference for cardiologists, endocrinologists, internists, and family physicians.

Contents:

Table of ContentsPART I

U.S. Studies
Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines* MD Anderson Cancer CenterHouston, Texas
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines* MD Anderson Cancer CenterHouston, Texas
The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.* ISCI / University of MiamiMiami, Florida
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs* Medical University of South CarolinaCharleston, South Carolina
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells(Rexlemestrocel-L) for the Treatment of Heart Failure.* Mesoblast Investigational Site 10757 - Cardiology, P.C.Birmingham, Alabama* Mesoblast Investigational Site 13262 - University of Alabama at Birmingham HospitalBirmingham, Alabama* Mesoblast Investigational Site 10779 - Mercy Gilbert Medical CenterGilbert, Arizona* (and 56 more...)

Europe
Allogeneic Stem Cell Therapy in Heart Failure* Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, RigshospitaletCopenhagen O, Denmark* Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, RigshospitaletCopenhagen O, Denmark
Stem Cells Therapy in Advanced Heart Failure* Celestino SarduNaples, Italy* Raffaele MarfellaNaples, Italy* Celestino SarduNapoli, Italy
Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease* 2014 Department of Cardiology, The Heart Centre, University Hospital RigshospitaletCopenhagen, Denmark
Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.* Hospital Universitario Puerta del MarCadiz, Spain* Hopistal Universitario Reina SofiaCordoba, Spain* Hospital Universitario Virgen de las NievesGranada, Spain* (and 6 more...)
Cell Therapy in HFpEF* University Medical Center LjubljanaLjubljana, Slovenia
Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure* Zentralklinik Bad BerkaBad Berka, Germany* Goethe University FrankfurtFrankfurt, Germany* Klinikum FuldaFulda, Germany* (and 3 more...)
Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI* Polsko-Amerykanskie Kliniki SercaUstron, Poland
Stem Cell Therapy in Non-Ischemic Non-treatable Dilated Cardiomyopathies II: a Pilot Study* The Heart Centre, Rigshospitalet University Hospital Copenhagen,Copenhagen, Denmark

Iran
IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients* Stem Cell and Regenerative Medicine Institute (SCARM)Tabriz, Islamic Republic of Iran
ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients* Stem Cell and Regenerative Medicine Institute (SCARM)Tabriz, Islamic Republic of Iran

China
Treating Heart Failure With hPSC-CMs* HelpTheraNanjing, Jiangsu, China

PART II
Type 1 Diabetes
US StudiesChinaChina/SpainSouth AmericaCanadaMiddle EastSweden
Type 2 Diabetes
US StudiesChinaNear EastVietnam

Other Thoughts